Skip to main content
logo
Caplin Point Laboratories Limited (NSE:CAPLIPOINT)
India flag India · Delayed Price · Currency is INR
1,565.80
-4.30 (-0.27%)
Apr 2, 2026, 3:29 PM IST

Caplin Point Laboratories Revenue

Caplin Point Laboratories had revenue of 5.43B INR in the quarter ending December 31, 2025, with 10.10% growth. This brings the company's revenue in the last twelve months to 20.92B, up 10.65% year-over-year. In the fiscal year ending March 31, 2025, Caplin Point Laboratories had annual revenue of 19.40B with 14.35% growth.

Revenue (ttm)
20.92B
Revenue Growth
+10.65%
P/S Ratio
5.70
Revenue / Employee
5.27M
Employees
3,966
Market Cap
119.17B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 202519.40B2.43B14.35%
Mar 31, 202416.96B2.28B15.51%
Mar 31, 202314.68B1.97B15.53%
Mar 31, 202212.71B2.09B19.64%
Mar 31, 202110.62B1.98B22.96%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Piramal Pharma88.71B
Alembic Pharmaceuticals72.67B
Strides Pharma Science47.26B
NATCO Pharma45.63B
Akums Drugs and Pharmaceuticals42.60B
Wockhardt31.74B
Eris Lifesciences30.65B
Alivus Life Sciences25.12B
Revenue Rankings

Caplin Point Laboratories News

More News